Best Pot Stocks | Aftermath Of Legalized Medical Marijuana on The US Stock Market - Kalkine Media

June 07, 2021 02:40 AM PDT | By Team Kalkine Media
Follow us on Google News:

America has legalized medical marijuana in 16 states and even for recreational use in many states including New York and California. With many more countries looking at decriminalizing the use of marijuana it is becoming more accepted as an asset in the marketplace. Like any biopharma company these stocks can at times be risky and investors should always assess their own financial objectives are aligned with their investments choices taking into factor in a big way risk exposure.

We’ve all heard about synthetic meat replacement products of late but have you heard of synthetic cannacinoids? Amyris Inc: is a Californian biotech company, most recently their quarter over quarter sales figures were up 96%, having a $3.5 billion market capitalization over the last year the stock has seen huge growth of approximately 600%. The technology Amyris Inc is developing could prove revolutionary to the Cannabis industry.

Truelieve Cannabis: This cannabis producer came into the spotlight after the acquisition of Harvest Health. Although already a national company in the united states, with the closure of this Harvest Health deal subject to shareholder approval will expand Truelieve’s horizons by adding the markets of Arizona, Pennsylvania and Maryland. Revenue growth for 2021 has reached 102% yoy recorded by the end of the Q1 as $194 million. Cronos Group: Known as the producer of the mature aged use of cannabidiol CBD products.

With year over year gains of 133%, induced perhaps by peoples growing need for their high quality products during the USA lockdowns, where marijuana delivery was considered an essential service. Cronos can offer an investor a classy cannabis product and a strong growth inventory. Curaleaf : another US based biotech firm positioned in Massachusetts, have shown first quarter revenue that rose 170% yoy reaching $260 million.

Curaleaf’s balance sheet is not yet profitable, but the acquisitions it completed in 2020 are still showing signs of growth. The company also has seen huge surges in retail and wholesale sales. Cara Therapeutics: This company has a comparatively small market cap although is able to show large returns. With highs in the share price posted in April 2021, a bargain entry point is currently being seen at the $12 price level.

This biotech has seen it’s price reach as high as $28 due to it’s high quality pain management cannabis and CBD products. Grow Generation Corp : You couldn’t talk about marijuana cultivation without bringing up Hydroponics.

One of the leading hydroponics equipment suppliers in the US was founded in 2014 and offers 50 retail centers. The company is not able to pay any dividends yet, but investors who are looking for growth stocks might be keen to look further into this stocks Price to earnings ratio.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.



Top Listed Companies